Translate this page into:
Atrophic pigmented dermatofibrosarcoma protuberans misdiagnosed as hyperpigmentation
Corresponding author: Dr. Hang Li, Department of Dermatology and Venereology, Peking University First Hospital, Xicheng, Beijing, China. drlihang@126.com
-
Received: ,
Accepted: ,
How to cite this article: Lin P, Yang Z, Tu P, Li H. Atrophic pigmented dermatofibrosarcoma protuberans misdiagnosed as hyperpigmentation. Indian J Dermatol Venereol Leprol 2021;87:693-5.
Sir,
Dermatofibrosarcoma protuberans is a rare cutaneous fibroblastic sarcoma of intermediate malignancy characterized histologically by spindle cells arranged in a storiform pattern.1 Although, several uncommon subtypes of dermatofibrosarcoma protuberans including pigmented or atrophic variants have been described, atrophic pigmented dermatofibrosarcoma protuberans is extremely rare, making it much more difficult to identify clinically. Here, we describe a case of atrophic pigmented dermatofibrosarcoma protuberans misdiagnosed as hyperpigmentation.
A 33-year-old female had an asymptomatic, bluish and slightly depressed lesion on her left upper back for ten years which was previously diagnosed as postinflammatory hyperpigmentation and did not receive any treatment. Three years ago after her last child birth, she noticed that the lesion began to gradually enlarge and developed peripheral erythema. No history of trauma could be identified. She was otherwise healthy and denied systemic symptoms or relevant family history. On dermatological examination, there was a firm, 1.6 × 1.3 cm, erythematous-to-bluish ill-defined, slightly depressed plaque on the left upper back [Figure 1a]. Nonpolarized dermoscopic evaluation with DERMOSCOPY-II (Dermat, Beijing) at 20x magnification revealed linear vessels within yellowish background with bluish structureless areas and shiny white streaks. No pigment network was observed [Figure 1b]. Histopathological analysis on low-power view revealed fascicles of densely packed spindle cells extending around fat tissue with a reduced dermal thickness [Figure 2a]. Cytologically, the monomorphic spindle cells had elongated darkly staining nuclei and bland cytoplasm with minimal mitotic figures [Figure 2b]. Scattered dendritic cells abundant in melanin were noticed [Figure 2b]. Immunohistochemical staining of spindle cells was positive for CD34 [Figure 2c] and vimentin, while negative for factor XIIIa and S-100. Melanin-laden dendritic cells were positive for S-100 [Figure 2d]. Modified Mohs micrographic surgery was performed to excise the lesion followed by secondary healing. No recurrence was observed at one-year follow-up.
Based on the clinicopathological features, more than ten variants of dermatofibrosarcoma protuberans including atrophic and pigmented variants have been described.2 Atrophic dermatofibrosarcoma protuberans was first described by Lambert in 1985 characterized by a slow-growing depressed plaque which revealed decreased dermal thickness by >50% compared with the surrounding dermis histologically.1,3 According to a single-center experience, atrophic variant accounts for only 1.7% (16/937) of all dermatofibrosarcoma protuberans cases.4 Pigmented dermatofibrosarcoma protuberans, also known as Bednar tumor, usually presents as a bluish plaque and is characterized by melanin-laden cells histologically.1 It predominantly occurs in Black population and accounts for approximately 1–5% of all dermatofibrosarcoma protuberans cases.1 With both characteristic histological features seen in our case, the diagnosis of atrophic pigmented dermatofibrosarcoma protuberans was established. A typical dermatofibrosarcoma protuberans lesion appears as an indurated protuberant plaque or nodule which may mimic dermatofibroma, neurofibroma, leiomyoma, keloid and desmoid tumors and other soft-tissue sarcomas such as Kaposi sarcoma and fibrosarcoma.5 The differential diagnosis of atrophic dermatofibrosarcoma protuberans, however, consists of another group of disorders including morphea, anetoderma, morphea-like or sclerosing basal cell carcinoma, atrophic dermatofibroma, atrophic scar, lipoatrophy, lymphocytoma etc.6 When it presents with bluish pigmentation, differential diagnoses of bruise, blue nevi, melanocytic nevi and malignant melanoma should also be taken into consideration.
So far, seven cases of atrophic pigmented dermatofibrosarcoma protuberans in addition to ours have been reported in PubMed, all presenting with a depressed pigmented plaque, three of which developed a nodule within the plaque [Table 1].4,7-10 Due to their atypical presentations, various incorrect diagnoses were considered, including lipoatrophy, hemangioma and neurofibroma.4,9 In our case, misdiagnosis of hyperpigmentation was made at initial visiting and only observation was recommended. It was gradual enlargement of the lesion that made us reconsider the diagnosis. Therefore, any solitary hyperpigmented lesion that does not resolve spontaneously or evolves on follow up should be biopsied to exclude malignancy even if it is not suspected clinically.
Age | Sex | Location | Size (mm) | Clinical presentations | Clinical differential diagnosis | Reference |
---|---|---|---|---|---|---|
24 | F | Infraorbital area | NA | Well-demarcated bluish depressed lesion | NA | Chuan et al., 19977 |
16 | F | Thigh | 12×15 | Multiple papules, plaques and nodules superimposed over several atrophic or indurated plaques | NA | Sathyanarayana et al., 200410 |
34 | F | Buttock | 11×12 | Pigmented plaque | NA | Taura et al., 20168 |
7 | M | Wrist | 20×40 | Hard hemispherical nodule in a red-brown irregular atrophic patch | Lipoatrophy | Zhang et al., 20189 |
8 | F | Forearm | 10×10 | Nodule over a bluish-black atrophic plaque | Hemangioma | Zhang et al., 20189 |
7 | M | Forearm | 5×5 | NA | NA | Xu et al., 20194 |
44 | M | Back | 25×25 | NA | Neurofibroma | Xu et al., 20194 |
Dermoscopy is a valuable non-invasive tool to differentiate a variety of cutaneous pigmented or non-pigmented tumors. However, it is not widely employed in the diagnosis of dermatofibrosarcoma protuberans. Bernard et al.11 summarized six dermoscopic features based on 15 classical cases of dermatofibrosarcoma protuberans: delicate pigment network, vessels, structureless light brown areas, shiny white streaks, pink background color and structureless hypo- to depigmented areas which are presented in a multicomponent pattern, suggesting the diagnosis of malignancy. Another recent study summarized dermoscopic features of 32 dermatofibrosarcoma protuberans cases as follows: features of vessels, pigment network and pinkish background presented in 26 (81.3%), 25 (78.1%) and 21 (65.6%) patients, respectively.12 On a literature search, we could not come across any specific dermoscopic features of atrophic pigmented dermatofibrosarcoma protuberans. Vessels and white streaks seen in our case were similar to the description of classic types. Structureless yellowish background may be a distinctive finding in atrophic type which might be the result of dermal atrophy and approximation of the subcutis to the epidermis. Bluish pigmentation likely corresponded to the distribution of melanin-laden cells in the dermis in pigmented dermatofibrosarcoma protuberans.
Modified Mohs micrographic surgery was performed to achieve complete resection with minimal sacrifice of normal tissue. No differences in terms of treatment options and prognosis between classical and atrophic or pigmented dermatofibrosarcoma protuberans have been delineated. However, atypical presentations often lead to misdiagnosis, delayed surgery as well as inadequate resection margins. Knowledge of the clinical characteristics dermoscopic features of this variant may aid in early diagnosis of atypical dermatofibrosarcoma protuberans.
Declaration of patient consent
The patient's consent is not required as the patient's identity is not disclosed or compromised.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Dermatofibrosarcoma protuberans: A comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013;30:13-28.
- [CrossRef] [Google Scholar]
- Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer. 2019;125:735-41.
- [CrossRef] [Google Scholar]
- Dermatofibrosarcoma non-protuberans: Description and report of five cases of a morpheaform variant of dermatofibrosarcoma. J Surg Oncol. 1985;28:7-11.
- [CrossRef] [Google Scholar]
- Atrophic dermatofibrosarcoma protuberans: A clinicopathological study of 16 cases. Pathology. 2019;51:615-20.
- [CrossRef] [Google Scholar]
- Atrophic dermatofibrosarcoma protuberans: Case report, review, and proposed molecular mechanisms. J Am Acad Dermatol. 2003;49:761-4.
- [CrossRef] [Google Scholar]
- Atrophic pigmented dermatofibrosarcoma presenting as infraorbital hyperpigmentation. Dermatology. 1997;194:65-7.
- [CrossRef] [Google Scholar]
- Case of pigmented dermatofibrosarcoma protuberans with atrophic change. J Dermatol. 2016;43:1231-2.
- [CrossRef] [Google Scholar]
- Two childhood cases of pigmented dermatofibrosarcoma protuberans with atrophic change. Eur J Dermatol. 2018;28:225-6.
- [CrossRef] [Google Scholar]
- Childhood onset dermatofibrosarcoma protuberans. Indian J Dermatol Venereol Leprol. 2004;70:310-2.
- [Google Scholar]
- Dermoscopy of dermatofibrosarcoma protuberans: A study of 15 cases. Br J Dermatol. 2013;169:85-90.
- [CrossRef] [Google Scholar]
- Dermoscopy of dermatofibrosarcoma protuberans: What do we know? Dermatol Pract Concept. 2019;9:139-45.
- [CrossRef] [Google Scholar]